Announcements Trials
Browse Landscape

Phase

Phase 1 13Phase 1/2 7Phase 2 1

Status

Recruiting 3Not yet recruiting 3Completed 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 7

Sponsor

Cancer Type

Other solid neoplasm 7

Conditions

Carcinoma, Non-Small-Cell Lung 52Neoplasms 28Neoplasm Metastasis 26Colorectal Neoplasms 26Recurrence 22Ovarian Neoplasms 22Pancreatic Neoplasms 21Prostatic Neoplasms 20Breast Neoplasms 20Squamous Cell Carcinoma of Head and Neck 19Melanoma 18Glioblastoma 16Lymphoma, Large B-Cell, Diffuse 14Lung Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Endometrial Neoplasms 13Triple Negative Breast Neoplasms 12Colonic Neoplasms 12Carcinoma, Renal Cell 11Stomach Neoplasms 10Leukemia, Myeloid, Acute 10Glioma 10Gastrointestinal Neoplasms 10Rectal Neoplasms 9Lymphoma, Follicular 9Lymphoma 9Head and Neck Neoplasms 9Small Cell Lung Carcinoma 8

Interventions

Magnetic Resonance Spectroscopy 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1/2 × Advanced Solid Tumor × 30 days × Clear all
NCT06833008 2026-06-01

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Ipsen

Phase 1/2 Recruiting
85 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT07617493 2026-06-01

Evaluation of ICP-B208 in Patients With Advanced Solid Tumors

Beijing InnoCare Pharma Tech Co., Ltd.

Phase 1/2 Not yet recruiting
539 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT07615660 2026-05-29

CVL006-T1003

Convalife (Shanghai) Co., Ltd.

Phase 1/2 Not yet recruiting
108 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05052268 2026-05-28

XTX202 in Patients With Advanced Solid Tumors

Xilio Development, Inc.

Phase 1/2 Completed
95 enrolled 49 charts
Other solid neoplasm

Advanced Solid Tumor

NCT05599048 2026-05-27

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

University of California, San Francisco

Phase 1/2 Recruiting
65 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05170958 2026-05-15

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Nanjing Leads Biolabs Co.,Ltd

Phase 1/2 Recruiting
396 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT07587879 2026-05-14

mRNA-LNP

IntraAb, Inc.

Phase 1/2 Not yet recruiting
60 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡